One study37 found that the prevalence of vitamin D deficiency in HT patients was significantly higher than that in the control group (70% vs 18.2%; P = 0.0001), but VDR BsmI, ApaI, and TaqI polymorphisms were not associated with HT risk. Here, VDR is linked to hematocrit.